Jay Jay Thaung Zaw

Senior International Medical Manager
Novo Nordisk A/S, Søborg, Denmark
Søborg, Hovedstaden, Denmark

Presentation(s):

• OC 40.4 - Concizumab efficacy results at 56-week cut-off in patients with hemophilia A/B without inhibitors: an intra-patient analysis from the phase 3 explorer8 study

  Monday, June 24, 2024
  15:30 – 15:45 ICT